From plasma to insights: enabling reliable liquid biopsy research

Liquid biopsy research depends on one critical factor: high-quality cfDNA extraction. This comprehensive white paper shows how leading cancer research institutions achieve consistent, scalable results using automated workflows.

What you'll discover

Overcome cfDNA extraction challenges: Learn how automated magnetic bead workflows address low DNA abundance, sample variability, and scaling issues that limit liquid biopsy research.

Real-world performance data: Access validated results from top cancer research centers, including peer-reviewed studies across early detection, treatment monitoring, and multi-cancer profiling applications.

Technical implementation guide: Get detailed specifications for the chemagic™ 360 system, including protocols for 0.5–18 mL sample processing and integration with existing laboratory systems.

Key research applications

This white paper features breakthrough studies in colorectal cancer detection, lung cancer classification, treatment response monitoring, and large-scale genomic profiling — demonstrating how consistent cfDNA extraction enables reliable downstream analysis.

Benefits for your research 
Standardized extraction protocols, reduced hands-on processing time, scalable high-throughput workflows, and validated compatibility with NGS, qPCR, and ddPCR platforms.

Download your copy now!

For research use only. Not for use in diagnostic procedures.